Bromocriptine is a medication currently used in the management and treatment of type 2 diabetes mellitus. It is an ergot alkaloid derivative in the dopamine D2 agonist class of drugs. This activity will review the indications, contraindications, and mechanism of action for bromocriptine as a valuable agent in managing type 2 diabetes mellitus, as well as its more traditional uses in Parkinson disease acromegaly pituitary prolactinomas. Further, throughout this activity, we will highlight the mechanism of action, adverse event profile, and other key factors pertinent to all inter-professional healthcare teams in managing patients with Type 2 diabetes mellitus, Parkinson disease, acromegaly, and pituitary prolactinomas using bromocriptine.

**Objectives:**
- Identify the mechanism of action of bromocriptine.
- Describe the potential adverse effects of bromocriptine.
- Review the appropriate monitoring for patients receiving therapy with bromocriptine.
- Summarize interprofessional team strategies for improving care coordination and communication to advance bromocriptine and improve outcomes.